Retinal Degenerative Diseases (Advances in Experimental Medicine and Biology, 723)
ISBN-13:
9781461406303
ISBN-10:
1461406307
Edition:
2012
Author:
John Ash, Robert E. Anderson, Joe G. Hollyfield, Matthew M. LaVail, Christian Grimm
Publication date:
2011
Publisher:
Springer
Format:
Hardcover
928 pages
Category:
Biotechnology
,
Biological Sciences
,
Genetics
,
Evolution
,
Anatomy
,
Basic Medical Sciences
,
Immunology
FREE US shipping
Book details
ISBN-13:
9781461406303
ISBN-10:
1461406307
Edition:
2012
Author:
John Ash, Robert E. Anderson, Joe G. Hollyfield, Matthew M. LaVail, Christian Grimm
Publication date:
2011
Publisher:
Springer
Format:
Hardcover
928 pages
Category:
Biotechnology
,
Biological Sciences
,
Genetics
,
Evolution
,
Anatomy
,
Basic Medical Sciences
,
Immunology
Summary
Retinal Degenerative Diseases (Advances in Experimental Medicine and Biology, 723) (ISBN-13: 9781461406303 and ISBN-10: 1461406307), written by authors
John Ash, Robert E. Anderson, Joe G. Hollyfield, Matthew M. LaVail, Christian Grimm, was published by Springer in 2011.
With an overall rating of 3.8 stars, it's a notable title among other
Biotechnology
(Biological Sciences, Genetics, Evolution, Anatomy, Basic Medical Sciences, Immunology) books. You can easily purchase or rent Retinal Degenerative Diseases (Advances in Experimental Medicine and Biology, 723) (Hardcover) from BooksRun,
along with many other new and used
Biotechnology
books
and textbooks.
And, if you're looking to sell your copy, our current buyback offer is $0.3.
Description
This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.
We would LOVE it if you could help us and other readers by reviewing the book
Book review
Congratulations! We have received your book review.
{user}
{createdAt}
by {truncated_author}